Shandong Tumor Hospital
3 clinical trials · Sponsor
◉ Watch Shandong Tumor Hospital
| Record | Firm | Date |
|---|---|---|
| Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer (NCT06986057) | Shandong Tumor Hospital | 2025-05-31 |
| Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy (NCT07309185) | Shandong Tumor Hospital | 2024-07-24 |
| Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer (NCT07320586) | Shandong Tumor Hospital | 2021-03-01 |
Track Shandong Tumor Hospital automatically
Every clearance here is in the API, with alerts when new ones post.